Momesso Denise P, Costa Filho Rubens Carmo, Costa João Luiz Ferreira, Saddy Felipe, Mesquita Ayla, Calomeni Marcela, Silva Claudia Dos Santos, Farret Jacqueline, Vasques Mariana Leon, Santos Aline G, Cabral Ana Paula Vieira, Ribeiro Dayane, Reis Luciana, Muino Maria de Fátima M, Vitorino Roberta Santiago, Monteiro Claudio Amorim, Tinoco Evandro, Volschan Andre
Hospital Pró-Cardíaco, Rio de Janeiro, RJ, Brasil.
Arch Endocrinol Metab. 2018 Oct;62(5):514-522. doi: 10.20945/2359-3997000000071.
Glycemic control has been increasingly recognized as a critical element in inpatient care, but optimal management of blood glucose in the hospital setting remains challenging. The aims of this study were to describe and evaluate the impact of the implementation of an inpatient multidisciplinary glucose control management program on glucose control in hospitalized patients.
Retrospective analysis of medical records and glucose monitoring data obtained by point- of-care testing (POCT) in hospitalized patients before (May 2014) and after (June 2015 and May 2017) the implementation of the program.
We analyzed 6888, 7290, and 7669 POCTs from 389, 545, and 475 patients in May 2014, June 2015, and May 2017, respectively. Hyperglycemia (≥ 180 mg/ dL) occurred in 23.5%, 19.6%, and 19.3% POCTs in May 2014, June 2015, and May/2017, respectively (p < 0.001), while severe hyperglycemia (≥ 300 mg/dL) was observed in 2.5%, 2.2%, and 1.8% of them, respectively (p = 0.003). Hyperglycemia (≥ 180 mg/dL) reduced significantly from May 2014 to June 2015 (16.3%, p < 0.001) and from May 2014 to May 2017 (178%, p < 0.001). No significant changes occurred in hypoglycemic parameters.
The implementation of an inpatient multidisciplinary glucose control management program led to significant reductions in hyperglycemic events. The key elements for this achievement were the development of institutional inpatient glycemic control protocols, establishment of a multidisciplinary team, and continuing educational programs for hospital personnel. Altogether, these actions resulted in improvements in care processes, patient safety, and clinical outcomes of hospitalized patients.
血糖控制在住院治疗中日益被视为关键要素,但在医院环境中对血糖进行最佳管理仍具有挑战性。本研究的目的是描述和评估实施住院多学科血糖控制管理计划对住院患者血糖控制的影响。
对实施该计划前(2014年5月)和实施后(2015年6月及2017年5月)住院患者的病历及通过即时检验(POCT)获得的血糖监测数据进行回顾性分析。
我们分别分析了2014年5月、2015年6月及2017年5月来自389例、545例及475例患者的6888次、7290次及7669次POCT。2014年5月、2015年6月及2017年5月的POCT中,血糖过高(≥180mg/dL)的发生率分别为23.5%、19.6%及19.3%(p<0.001),而严重血糖过高(≥300mg/dL)的发生率分别为2.5%、2.2%及1.8%(p = 0.003)。从2014年5月至2015年6月(降低16.3%,p<0.001)以及从2014年5月至2017年5月(降低17.8%,p<0.001),血糖过高(≥180mg/dL)情况显著减少。低血糖参数未发生显著变化。
实施住院多学科血糖控制管理计划导致血糖过高事件显著减少。取得这一成果的关键要素包括制定机构住院患者血糖控制方案、组建多学科团队以及为医院工作人员开展持续教育项目。总体而言,这些举措改善了住院患者的护理流程、患者安全及临床结局。